The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial
Abstract
The efficacy and cost-effectiveness of low-dose spiral computed tomography (LDCT) screening in heavy smokers is currently under evaluation worldwide. Our screening program started with a pilot study on 1035 volunteers in Milan in 2000 and was followed up in 2005 by a randomized trial comparing annual or biennial LDCT with observation, named Multicentric Italian Lung Detection. This included 4099 participants, 1723 randomized to the control group, 1186 to biennial LDCT screening, and 1190 to annual LDCT screening. Follow-up was stopped in November 2011, with 9901 person-years for the pilot study and 17 621 person-years for Multicentric Italian Lung Detection. Forty-nine lung cancers were detected by LDCT (20 in biennial and 29 in the annual arm), of which 17 were identified at baseline examination; 63% were of stage I and 84% were surgically resectable. Stage distribution and resection rates were similar in the two LDCT arms. The cumulative 5-year lung cancer incidence rate was 311/100 000 in the control group, 457 in the biennial, and 620 in the annual LDCT group (P=0.036); lung cancer mortality rates were 109, 109, and 216/100 000 (P=0.21), and total mortality rates were 310, 363, and 558/100 000, respectively (P=0.13). Total mortality in the pilot study was similar to that observed in the annual LDCT arm at 5 years. There was no evidence of a protective effect of annual or biennial LDCT screening. Furthermore, a meta-analysis of the four published randomized trials showed similar overall mortality in the LDCT arms compared with the control arm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596 · cited 1×
“Lung cancer incidence and mortality have constantly declined during the last three decades in male populations of Europe and the US, mainly as a consequence of effective smoking control policies (Jemal et al., 2010; La Vecchia et al., 2010).”
BackgroundReduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,508
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Management of Lung Nodules Detected by Volume CT Scanning
van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R., van Iersel, C. A., van den Bergh, K. A. M., van 't Westeinde, S., van der Aalst, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906085 · Cited by 820
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., Calabrò, E., Croce, C. M., Pastorino, U., & Sozzi, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100048108 · Cited by 722
Self-citationBassler, D. (2010) · JAMA · doi:10.1001/jama.2010.310 · Cited by 611
Computed Tomography Screening and Lung Cancer Outcomes
Bach, P. B. (2007) · JAMA · doi:10.1001/jama.297.9.953 · Cited by 567
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
Sozzi, G., Conte, D., Leon, M., Cirincione, R., Roz, L., Ratcliffe, C., Roz, E., Cirenei, N., Bellomi, M., Pelosi, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.006 · Cited by 552
Self-citationPastorino, U., Bellomi, M., Landoni, C., De Fiori, E., Arnaldi, P., Picchio, M., Pelosi, G., Boyle, P., & Fazio, F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14188-8 · Cited by 452
Self-citationInfante, M., Cavuto, S., Lutman, F. R., Brambilla, G., Chiesa, G., Ceresoli, G., Passera, E., Angeli, E., Chiarenza, M., Aranzulla, G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0076oc · Cited by 379
Vazquez, M., Carter, D., Brambilla, E., Gazdar, A., Noguchi, M., Travis, W. D., Huang, Y., Zhang, L., Yip, R., Yankelevitz, D. F., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.08.009 · Cited by 214
Interstitial lung diseases in a lung cancer screening trial
Sverzellati, N., Guerci, L., Randi, G., Calabrò, E., La Vecchia, C., Marchianò, A., Pesci, A., Zompatori, M., & Pastorino, U. (2011) · European Respiratory Journal · doi:10.1183/09031936.00201809 · Cited by 173
Self-citationSozzi, G., Roz, L., Conte, D., Mariani, L., Andriani, F., Verderio, P., & Pastorino, U. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji432 · Cited by 163
Self-citationSozzi, G., Musso, K., Ratcliffe, C., Goldstraw, P. G., Pierotti, M. A., & Pastorino, U. (1999) · PubMed · Cited by 138
Self-citationPastorino, U. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605660 · Cited by 120
Self-citationPlasma DNA Quantification in Lung Cancer Computed Tomography Screening
Sozzi, G., Roz, L., Conte, D., Mariani, L., Andriani, F., Vullo, S. L., Verri, C., & Pastorino, U. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1068oc · Cited by 103
Self-citationLung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Calabrò, E., Randi, G., Vecchia, C. L., Sverzellati, N., Marchianò, A. V., Villani, M., Zompatori, M., Cassandro, R., Harari, S. A., & Pastorino, U. (2009) · European Respiratory Journal · doi:10.1183/09031936.00049909 · Cited by 95
Self-citationSverzellati, N., Cademartiri, F., Bravi, F., Martini, C., Gira, F. A., Maffei, E., Marchianò, A. V., Vecchia, C. L., Filippo, M. D., Kuhnigk, J., et al. (2011) · Radiology · doi:10.1148/radiol.11110364 · Cited by 92
Self-citationPulmonary Nodules: Volume Repeatability at Multidetector CT Lung Cancer Screening
Marchianò, A. V., Calabrò, E., Civelli, E. M., Tolla, G. D., Frigerio, L. F., Morosi, C., Tafaro, F., Ferri, E., Sverzellati, N., Camerini, T., et al. (2009) · Radiology · doi:10.1148/radiol.2513081313 · Cited by 72
Self-citationAssessment of lung-cancer mortality reduction from CT Screening
Henschke, C. I., Boffetta, P., Gorlova, O. Y., Yip, R., DeLancey, J. O., & Foy, M. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.10.025 · Cited by 69
Is our natural-history model of lung cancer wrong?
Bach, P. B. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70176-1 · Cited by 61
Promoter Polymorphisms and Transcript Levels of Nicotinic Receptor CHRNA5
Falvella, F. S., Galvan, A., Colombo, F., Frullanti, E., Pastorino, U., & Dragani, T. A. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq264 · Cited by 43
Self-citationMicroRNAs and lung cancer: From markers to targets
Sozzi, G., Pastorino, U., & Croce, C. M. (2011) · Cell Cycle · doi:10.4161/cc.10.13.15712 · Cited by 37
Self-citationPastorino, U., Landoni, C., Marchianò, A. V., Calabrò, E., Sozzi, G., Miceli, R., Picchio, M., Mariani, L., Messa, C., & Fazio, F. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181bbf1dc · Cited by 29
Self-citationElevated levels of the acute‐phase serum amyloid are associated with heightened lung cancer risk
Cremona, M., Calabrò, E., Randi, G., Bortoli, M. D., Mondellini, P., Verri, C., Sozzi, G., Pierotti, M. A., Vecchia, C. L., Pastorino, U., et al. (2010) · Cancer · doi:10.1002/cncr.24868 · Cited by 26
Self-citation
Cited by
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M., Clark, S. D., Weber, R. P., Enyioha, C., Malo, T. L., Brenner, A. T., Armstrong, C., et al. (2021) · JAMA · doi:10.1001/jama.2021.0377 · Cited by 633
European position statement on lung cancer screening
Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30861-6 · Cited by 587
Self-citation
Metadata
- Authors
- Pastorino, U., Rossi, M., Rosato, V., Marchianò, A., Sverzellati, N., Morosi, C., Fabbri, A., Galeone, C., Negri, E., Sozzi, G., Pelosi, G., & La Vecchia, C.
- Venue
- European Journal of Cancer Prevention
- Published
- 2012-05
- Volume
- 21
- Issue
- 3
- Pages
- 308-315
- ISSN
- 0959-8278 (ISSN-L)
- OpenAlex
- W1991563667
- Cited by
- 414
- References
- 27
- FWCI
- 27.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.